OTC Nasal Antiseptic NanoBio Protect ‘Lethal’ In COVID-19 In Vitro Tests, Amazon Launch Soon
Executive Summary
BlueWillow Biologics points to recent in vitro tests it conducted with Public Health England showing NanoBio Protect killed COVID-19 as additional support for using nasal antiseptics to help prevent infections from the novel coronavirus. The firm also will soon offer sales of NanoBio Protect on Amazon.
You may also be interested in...
Nanoceutical’s Absorption Studies Don’t Pick Up Disease Claims In NAD Review
National Advertising Division, on challenge by Council for Responsible Nutrition, recommends Nanoceutical Solutions discontinue efficacy and establishment claims for Nano Glutathione.
NanoBio Nasal Antiseptic, Burst Oral-Care Probiotics And More: Personal Care Launch News
Recent personal-care product launches show companies innovating in emerging frontiers and hazily regulated territory with probiotic oral care, over-the-counter fungal nail care and nasal antiseptic care. Elsewhere, sensitive skin specialist Cetaphil introduces ultra-moisturizing products, and Nestle Health Sciences’ Atrium Innovations launches a line of nutritional supplements for skin, hair and nail health.
COVID-19 Consumer Health Market: Germ-Blocking Nasal Spray, 99.99% Effective Sanitizer, ‘Mask’ To Moisturize Hands
Sensory Cloud’s small study showed FEND nasal solution cut by 99% exhalation of bioaerosol to block COVID-19. Global BioProtect’s hand sanitizer with proprietary antibacterial technology eliminates 45 bacteria, fungi and virus. Trilogy Labs’ solution replenishes moisture in hands irritated by sanitizers.